Sort   by:  
 Page size 
UnknownA novel interaction between HER2/neu and cyclin E in breast cancer.
Not available
S-EPMC2900397 | biostudies-literature
UnknownBioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
Not available
S-EPMC5880531 | biostudies-literature
UnknownPrognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
Not available
S-EPMC9227690 | biostudies-literature
UnknownComparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Not available
S-EPMC8340363 | biostudies-literature
UnknownFinal report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.
Not available
S-EPMC4143091 | biostudies-literature
UnknownPrimary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Not available
S-EPMC4922316 | biostudies-literature
UnknownTumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation.
Not available
S-EPMC9444971 | biostudies-literature
UnknownCurrent Landscape of Immunotherapy in Breast Cancer: A Review.
Not available
S-EPMC8452050 | biostudies-literature
UnknownCell populations in human breast cancers are molecularly and biologically distinct with age.
Not available
S-EPMC12705435 | biostudies-literature
UnknownNivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study.
Not available
S-EPMC8387440 | biostudies-literature
Sort   by:  
 Page size